A mutant nad(p)h-quinone dehydrogenase, engineered microorganisms and uses thereof
By mutating the 27th amino acid of Corynebacterium glutamicum NAD(P)H-quinone dehydrogenase to aspartic acid or glycine, the problem of insufficient threonine production performance in the existing technology was solved, and a significant improvement in threonine yield and conversion rate was achieved.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- MEIHUA BIOTECH LANGFANG CO LTD
- Filing Date
- 2024-12-06
- Publication Date
- 2026-06-09
AI Technical Summary
In the existing technology, there are still shortcomings in improving the production performance of L-threonine by Corynebacterium glutamicum, and there is a lack of effective genetic engineering targets and methods. There are also few studies on the impact of NAD(P)H-quinone dehydrogenase mutants on amino acid production.
By mutating specific amino acids in the NAD(P)H-quinone dehydrogenase of Corynebacterium glutamicum to make its 27th amino acid aspartic acid or glycine, a mutant NAD(P)H-quinone dehydrogenase was developed to improve the synthesis and conversion rate of threonine.
It significantly improved the yield and conversion rate of threonine, provided a new genetic engineering strategy, and enhanced the production performance of the strain.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3